Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
- L. K. Schluger, P. Sheiner, +8 authors H. Bodenheimer
- Medicine
- Hepatology
- 1 May 1996
Recurrent infection with hepatitis C virus (HCV) is almost universal following orthotopic liver transplantation although clinical severity varies. Data on 135 patients who underwent transplantation… Expand
Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation
- M. Gambarin-Gelwan, D. Wolf, R. Shapiro, M. Schwartz, A. Min
- Medicine
- American Journal of Gastroenterology
- 1 June 2000
OBJECTIVE:Recognition of hepatocellular carcinoma (HCC) is important in the management of patients awaiting liver transplantation. HCCs >5 cm in diameter are at high risk to recur after transplant.… Expand
Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients.
- D. Wolf, M. Freni, +6 authors H. Bodenheimer
- Medicine
- Liver transplantation and surgery : official…
- 1 November 1997
Hepatic artery thrombosis occurs in 4% to 10% of adult patients and in up to 26% of children undergoing liver transplantation. Aspirin has been used to prevent this complication but may increase… Expand
Surgical Treatment of Hepatocellular Carcinoma beyond Milan Criteria. Results of Liver Resection, Salvage Transplantation, and Primary Liver Transplantation
- M. Facciuto, B. Koneru, +9 authors P. Sheiner
- Medicine
- Annals of Surgical Oncology
- 5 March 2008
BackgroundThere is no clear consensus regarding the best treatment strategy for patients with advanced hepatocellular carcinoma (HCC).MethodsPatients with cirrhosis and HCC beyond Milan who had… Expand
Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response
- M. Facciuto, M. Singh, +7 authors D. Wolf
- Medicine
- Journal of surgical oncology
- 1 June 2012
Loco‐regional therapies for cirrhotic patients with hepatocellular carcinoma (HCC) who are awaiting liver transplantation (OLT) attempt to prevent tumor progression. However, there is limited data… Expand
Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria.
- M. Facciuto, C. Rochon, +6 authors P. Sheiner
- Medicine
- HPB : the official journal of the International…
- 1 August 2009
BACKGROUND
The optimal role of surgery in the management of hepatocellular carcinoma (HCC) is in continuous evolution.
OBJECTIVE
The objective of this study was to analyse survival rates after… Expand
Mycophenolate Mofetil for Autoimmune Hepatitis: A Single Practice Experience
- D. Wolf, Lizza Bojito, M. Facciuto, E. Lebovics
- Medicine
- Digestive Diseases and Sciences
- 1 November 2009
Autoimmune hepatitis (AIH) is refractory to standard therapy with prednisone and azathioprine in 20% of patients. Investigators are exploring alternative immunosuppressant treatments, including… Expand
Waiting for a liver: Hidden costs of the organ shortage
- D. Brand, D. Viola, Pretam Rampersaund, P. Patrick, W. Rosenthal, D. Wolf
- Medicine
- 1 April 2003
Impact of Cardiovascular Risk Factors on Long-Term Mortality After Liver Transplantation
Immunosuppression with calcineurin inhibitors has contributed to an increased prevalence of hypertension, diabetes, and hypercholesterolemia in patients receiving liver transplantation. This study… Expand